Uroxatral (uro-ZEH-tral), a new alpha-blocker for benign prostatic hypertrophy

You'll soon see ads for Uroxatral (uro-ZEH-tral), a new alpha-blocker for benign prostatic hypertrophy.

It's the fourth alpha-blocker for BPH...along with Flomax (tamsulosin), Hytrin (terazosin), and Cardura (doxazosin).

They are all similarly effective for BPH...but the newer ones, Uroxatral (alfuzosin) and Flomax, seem to be better tolerated.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote